SCM
SIOX

Suvretta Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Suvretta Capital Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,914,000
Closed -$1.66M – 111
2022
Q3 		$1.66M Hold
5,914,000
– – 0.07% 66
2022
Q2 		$2.13M Hold
5,914,000
– – 0.08% 77
2022
Q1 		$3.96M Hold
5,914,000
– – 0.12% 66
2021
Q4 		$7.63M Buy
5,914,000
+425,000
+8% +$754K 0.15% 66
2021
Q3 		$11.9M Hold
5,489,000
– – 0.2% 60
2021
Q2 		$15M Hold
5,489,000
– – 0.23% 67
2021
Q1 		$14.3M Buy
+5,489,000
New +$15.5M 0.21% 66

Other funds holding SIOX

RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $674M AUM 24.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return